• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

IN8bio, Inc.

IN8bio, Inc.

Public
IN8B
United States
SectorHealthcare
CountryUnited States
Market cap14.67M
A clinical-stage biopharmaceutical company developing gamma-delta T-cell immunotherapies.

Where to buy IN8bio, Inc. (IN8B)

IN8B trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare